Ellis Wilson
No más puestos en curso
Perfil
Ellis Wilson worked as an Executive Director of Commercial Strategy at PPD, Inc. He then worked as a Vice President of Global Clinical Operations at VistaGen Therapeutics, Inc. from 2021 to 2022.
Prior to that, he was a Vice President of Product Development at Wavodyne Therapeutics, Inc. and a Vice President of Clinical Development at NRX Pharmaceuticals, Inc. Wilson holds a graduate degree from West Chester University of Pennsylvania, an MBA from Erivan K.
Haub School of Business, and graduate and undergraduate degrees from Temple University School of Pharmacy and Philadelphia College of Pharmacy, respectively.
Antiguos cargos conocidos de Ellis Wilson.
| Empresas | Cargo | Fin |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/11/2022 |
Wavodyne Therapeutics, Inc.
 Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Wavodyne Therapeutics, Inc. develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuro-inflammatory processes. The firm also provides research and development services. The company was founded by Jim New and is headquartered in Rochester, NY. | Corporate Officer/Principal | - |
| PPD, INC. | Corporate Officer/Principal | - |
| NRX PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Ellis Wilson.
| Erivan K. Haub School of Business | Masters Business Admin |
| Temple University School of Pharmacy | Graduate Degree |
| West Chester University of Pennsylvania | Graduate Degree |
| Philadelphia College of Pharmacy | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| VISTAGEN THERAPEUTICS, INC. | Health Technology |
| NRX PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Wavodyne Therapeutics, Inc.
Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Wavodyne Therapeutics, Inc. develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuro-inflammatory processes. The firm also provides research and development services. The company was founded by Jim New and is headquartered in Rochester, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Ellis Wilson
